Editorial: Plant metabolites in drug discovery: the prism perspective between plant phylogeny, chemical composition, and medicinal efficacy, volume III
Front Pharmacol
.
2024 Dec 13:15:1530039.
doi: 10.3389/fphar.2024.1530039.
eCollection 2024.
Authors
Da-Cheng Hao
1
,
Yao-Xuan Wang
1
,
Richard W Spjut
2
,
Chun-Nian He
3
Affiliations
1
Department of Environment Science and Engineering, Biotechnology Institute, Dalian Jiaotong University, Dalian, China.
2
World Botanical Associates Inc., Bakersfield, CA, United States.
3
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
PMID:
39734409
PMCID:
PMC11672199
DOI:
10.3389/fphar.2024.1530039
No abstract available
Keywords:
bioactivity; omics; pharmacophylogeny; phylogenomics; phytometabolite.
Publication types
Editorial
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.